Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1336831 | 0.80 | MAPT (0.50) | MAPT | |
| SCHEMBL16707474 | 0.77 | NCEH1 (0.31) | NCEH1 | |
| SCHEMBL2495997 | 0.72 | CYP1A2 (0.52) | MAPT | |
| SCHEMBL18854378 | 0.72 | NCEH1 (0.35) | NCEH1PTPN1TDP2NSD2HSP90AA1 | |
| SCHEMBL97153 | 0.71 | TSHR (0.44) | MAPT | |
| SCHEMBL2089379 | 0.71 | ACHE (0.41) | MAPT | |
| SCHEMBL141853 | 0.70 | ACHE (0.44) | MAPT | |
| SCHEMBL49632 | 0.70 | TSHR (0.43) | — | |
| SCHEMBL2502170 | 0.70 | NCEH1 (0.53) | NCEH1MAPT | |
| SCHEMBL30046229 | 0.69 | TDP2 (0.40) | TDP2NSD2HSP90AA1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0152759-B1 | AMINOISOTHIAZOLE COMPOUNDS | BASF Aktiengesellschaft (DE) | 1989-08-23 | — | — | EP | claimed |
| EP-0150034-B1 | DERIVATIVES OF 2-AMINOTHIOPHENE | BASF Aktiengesellschaft (DE) | 1989-08-02 | — | — | EP | claimed |
| US-4785116-A | Aminoisothiazole compounds | BASF AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | claimed |
| CN-117957265-A | Process for producing dihydroxy compound and process for producing regenerated resin | 三菱瓦斯化学株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-117916325-A | Thermoplastic resin composition, molded article, method for producing thermoplastic resin composition, and method for improving transmittance | 三菱瓦斯化学株式会社 | 2024-04-19 | — | — | CN | disclosed |
| US-20230295373-A1 | THERMOPLASTIC RESIN COMPOSITION FOR OPTICAL MATERIAL, MOLDED ARTICLE, COMPOUNDING AGENT, METHOD FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION, AND METHOD FOR IMPROVING TRANSMISSIVITY | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-4198092-A1 | THERMOPLASTIC RESIN COMPOSITION FOR OPTICAL MATERIAL, MOLDED ARTICLE, COMPOUNDING AGENT, METHOD FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION, AND METHOD FOR IMPROVING TRANSMISSIVITY | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-06-21 | — | — | EP | disclosed |
| CN-116096779-A | Thermoplastic resin composition for optical material, molded article, compounding agent, method for producing thermoplastic resin composition, and method for improving transmittance | 三菱瓦斯化学株式会社 | 2023-05-09 | — | — | CN | disclosed |
| WO-2023068290-A1 | THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE, AND METHOD FOR PRODUCING AND METHOD FOR IMPROVING TRANSMITTANCE OF THERMOPLASTIC RESIN COMPOSITION | 三菱瓦斯化学株式会社 | 2023-04-27 | — | — | WO | disclosed |
| CN-115335443-A | Method for producing regenerated resin | 三菱瓦斯化学株式会社 | 2022-11-11 | — | — | CN | disclosed |
| US-20220098660-A1 | ARTICLES HAVING LOCALIZED MOLECULES DISPOSED THEREON AND METHODS OF PRODUCING SAME | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2022-03-31 | — | — | US | disclosed |
| US-20070179173-A1 | Carbostyril compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| EP-1797082-A1 | CARBOSTYRIL COMPOUND | Otsuka Pharmaceutical Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006035954-A1 | CARBOSTYRIL COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-04-06 | — | — | WO | disclosed |
| EP-0152759-B1 | AMINOISOTHIAZOLE COMPOUNDS | BASF Aktiengesellschaft (DE) | 1989-08-23 | — | — | EP | disclosed |
| EP-0150034-B1 | DERIVATIVES OF 2-AMINOTHIOPHENE | BASF Aktiengesellschaft (DE) | 1989-08-02 | — | — | EP | disclosed |
| US-4785116-A | Aminoisothiazole compounds | BASF AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | disclosed |
| EP-0152759-A1 | Aminoisothiazole compounds | BASF Aktiengesellschaft (DE) | 1985-08-28 | — | — | EP | disclosed |
| EP-0150034-A2 | Derivatives of 2-aminothiophene | BASF Aktiengesellschaft (DE) | 1985-07-31 | — | — | EP | disclosed |
| EP-0150034-A2 | Derivatives of 2-aminothiophene | BASF Aktiengesellschaft (DE) | 1985-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179173-A1 | Carbostyril compound | GTF2F1, F3, GTF2F2 | NCEH1 2320/4885PTPN1 1691/4885TDP2 4438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.